All News
Filter News
Found 808,679 articles
-
Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team Welcomes Professional Boxer Austin Dwayne Trout
4/25/2019
Austin will act as a spokesperson for the company to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers.
-
CoreBiome Announces Leading Microbiome Researcher Rob Knight as Scientific Advisor
4/25/2019
CoreBiom announced that Rob Knight, Professor and Director of the Center for Microbiome Innovation at the University of California San Diego, has joined its scientific advisory board.
-
Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland
4/25/2019
Nearly 5,000 square foot facility will manufacture early stage clinical trial material for gene therapy trials
-
Twist Bioscience Announces Synthetic DNA Biosecurity Publication in Frontiers
4/25/2019
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a new biosecurity publication titled ‘Next Steps for Access to Safe, Secure DNA Synthesis’,
-
Eyenuk Will Announce Results From Prospective, Multi-Center, Pivotal Clinical Trial on the EyeArt® AI Eye Screening System at ARVO Conference
4/25/2019
Artificial Intelligence (AI) Technology Developed To Make In-Clinic, Real-Time Diabetic Retinopathy Screening Possible for Any Physician
-
Björn Carlsson, CEO of Monocl, accepted into Forbes Young Entrepreneur Council
4/25/2019
Young Entrepreneur Council is an invitation-only community for the world’s most successful entrepreneurs.
-
Pharmapod Partners With FIP to Improve Patient Safety
4/25/2019
Partnership, to offer an infrastructure for effective incident management and continuous quality improvement for pharmacists internationally.
-
Kindred Biosciences to Announce First Quarter 2019 Financial Results
4/25/2019
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Thursday, May 9, 2019 [25-April-2019] SAN FRANCISCO , April 25, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its first qua
-
Novaliq and BLP Management Group Established New Company, Betaliq Inc., to Leverage EyeSol Technology to Treat Glaucoma
4/25/2019
Novaliq GmbH, a specialty pharmaceutical company for the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol® and BLP Management group announce the formation and funding of Betaliq Inc., a new company located in Tampa, Florida.
-
AcelRx to announce first quarter 2019 results and provide an update on the company's business on Wednesday, May 8th, 2019
4/25/2019
AcelRx Pharmaceuticals, Inc. announced that it will release first quarter financial results after market close on Wednesday, May 8th, 2019.
-
IQVIA’s OCE Technology Platform Selected by Salehiya Medical to Enhance Customer Experience in Saudi Arabia
4/25/2019
IQVIA™ (NYSE:IQV) today announced that Salehiya Medical, a leading Saudi Arabian healthcare distribution company, has selected IQVIA Technologies’ Orchestrated Customer Engagement (OCE) platform for deployment within its medical supplies division to harmonize customer interactions across multiple marketing channels and optimize performance.
-
CSL Behring Delivers on its Continued Commitment to Alpha 1 Patients with FDA Approval of Convenient Single-Vial Dosing for ZEMAIRA® [Alpha1-Proteinase Inhibitor (Human)]
4/25/2019
New vial options deliver on CSL Behring's heritage of innovation by providing more alternatives to patients
-
Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2019
4/25/2019
At the Annual General Meeting of Immunicum AB (publ), reg. no 556629-1786, on April 25, 2019 the AGM adopted, inter alia, the following resolutions.
-
Concert Pharmaceuticals to Report First Quarter 2019 Financial Results on May 2, 2019
4/25/2019
Concert Pharmaceuticals, Inc. announced that it will report its first quarter 2019 financial results on Thursday, May 2, 2019, before the U.S. financial markets open.
-
Intersect ENT to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
4/25/2019
Intersect ENT, Inc. announced that management will participate in the 2019 Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14, 2019 at the Encore Hotel in Las Vegas, including a Q&A session at 1:40 p.m. PT.
-
DURECT Appoints Two New Board Members
4/25/2019
DURECT Corporation announced the appointment of two new members to its board of directors.
-
Biocodex Announces New Probiotic Supplement for Babies
4/25/2019
FlorastorBaby is a daily supplement that starts children on the path to digestive and immune health
-
Allegro Ophthalmics Expands Its Anti-Integrin Portfolio with New Front-of-the-Eye Drug Candidate ALG-1007 for the Treatment of Dry Eye Disease
4/25/2019
Allegro Ophthalmics, LLC, a privately held biopharmaceutical company focused on the development of novel anti-integrin therapies for the treatment of ocular diseases, today announced the expansion of the company’s anti-integrin portfolio with the new front-of-the-eye-drug candidate ALG-1007
-
VivoPlex expands its Board with appointment of new Non-Executive Director
4/25/2019
David Wilkinson brings experience of strategy & governance in growth firms
-
Roche Presented Caprion Biosciences' Data on Targeted Mass Spectrometry for Clinical Proteomics
4/25/2019
Roche presented data demonstrating the use of GCP-compliant quantitative MRM mass spectrometry platform in clinical trials